By Health Impact News
Dr. Theresa Deisher recently granted an interview with the VAXXED team to discuss, among other things, vaccines and autism.
Theresa Deisher, Ph.D., is the president of Sound Choice Pharmaceutical Institute (SCPI), a cutting edge biomedical research organization.
Dr. Deisher is a genetic engineer with over 20 years experience in the pharmaceutical industry, from basic human biology through clinical trials.
Dr. Deisher obtained her Ph.D. in Molecular and Cellular Physiology from Stanford University and has spent over 20 years in commercial biotechnology. Prior to founding AVM Biotechnology and Sound Choice Pharmaceutical Institute (SCPI), she worked with leading biotechnology companies, including Genentech, Repligen, ZymoGenetics, Immunex and Amgen.
Dr. Deisher is an inventor on 23 issued U.S. patents, and her discoveries have led to clinical trials of FGF18 for osteoarthritis and cartilage repair, and for Factor XIII for surgical bleeding. Dr. Deisher was the first person to discover adult cardiac derived stem cells, and has been a champion of adult stem cell research, both professionally and privately, for two decades. Dr. Deisher was a plaintiff in the U.S. federal lawsuit to prohibit use of federal tax payer dollars for embryo destructive research, which was instrumental in steering science towards adult stem cell research, which has led to 14 U.S. FDA approved adult stem cell products and the Washington Post Dec 2013 headline “Scientists Go Ethical in 2013.”
AVM Biotechnology is the marquee prolife biotech company worldwide, certifying that it does not use morally illicit material in any process. SCPI’s mission is to end human trafficking in biomedical research.
Discovering the Link Between Fetal Tissue in Vaccines and Autism
Dr. Deisher states in her VAXXED interview that she looked at the rise in autism rates in the U.K. and its link to the MMR vaccine, originally discovered and published by Dr. Andrew Wakefield, and how the medical establishment tried to discredit Dr. Wakefield’s research.
She notes that one reason given to try and discredit Dr. Wakefield’s research was that MMR vaccination rates remained steady both prior to and after the spike in autism rates in 1988.
However, what she discovered that was not reported was that the manufacturer of the MMR vaccine switched from animal cells to develop cultures to human fetal cells from aborted babies in 1988.
So she had one of her Ph.D. researchers investigate the matter more thoroughly, and compare autism rates to the use of human fetal cells in vaccines, and she discovered that every time fetal cells were introduced into the manufacture of vaccines, autism rates increased.